Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?

In the past decade, immune checkpoint inhibitor (ICI) therapy significantly improved the prognosis of patients with cancer. Despite impressive and often unprecedented response rates, a significant portion of the patients fails to benefit from this treatment. Additional strategies to improve ICI effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Winnie G, Lutgens, Esther, Seijkens, Tom T P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442479/
http://dx.doi.org/10.1136/jitc-2022-005611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442479/
http://dx.doi.org/10.1136/jitc-2022-005611

Ejemplares similares